A Study Comparing Two Topicals in the Treatment of Acne Vulgaris

Completed · Phase 1

Conditions studied: Acne Vulgaris

In brief

A Randomized, Evaluator-Blinded, Bilateral Comparison Study to Evaluate the Safety and Efficacy of Two Topicals in the Treatment of Subjects With Acne Vulgaris (Study FX2018-23).

Key facts

Study ID

NCT03743038

Run by

Vyne Therapeutics Inc.

People needed

12

Starts

2018-11-20

Expected to finish

2019-02-11

Last updated by the study team

2021-04-06

Who can join

Age: 12 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Has facial acne vulgaris with:
• 16 inflammatory lesions (papules, pustules) The inflammatory lesion count on the right and left side of the face should be similar IGA score of moderate (3) on both the right and left side of the face

You may not qualify if…

• Acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne), or any dermatological condition of the face or facial hair (eg, beard, sideburns, mustache) that could interfere with the clinical evaluations.
• More than two facial nodules/cysts
• Sunburn on the face

Where it is running

• Site #01 — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.